Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-10 Harrell James Archie Jr Chief Commercial Officer Purchase +1,093 $1.57 $2K 36,766
2021-06-10 Harrell James Archie Jr Chief Commercial Officer Purchase +7,493 $2.28 $17K 35,673
2021-01-26 Harrell James Archie Jr Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2020-12-10 Harrell James Archie Jr Chief Commercial Officer Purchase +171 $2.28 $390 28,180
2020-06-10 Harrell James Archie Jr Chief Commercial Officer Purchase +6,391 $2.28 $15K 28,009
2020-06-09 Harrell James Archie Jr Chief Commercial Officer Purchase +10,000 $2.50 $25K 21,618
2020-04-09 Harrell James Archie Jr Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +268,000 268,000
2019-12-10 Harrell James Archie Jr Chief Commercial Officer Purchase +3,064 $2.85 $9K 11,618
2019-06-10 Harrell James Archie Jr Exec. VP, Mktg & External Comm Purchase +4,398 $2.85 $13K 8,554

Page 1 of 1 · 9 trades